| Systematic (IUPAC) name | |
|---|---|
| (8β)- N,N- diethyl- 6-propyl- 9,10- didehydroergoline- 8- carboxamide | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Controlled in the United States via the Federal Analog Act but only if it is intended for human consumption. |
| Routes | Oral |
| Pharmacokinetic data | |
| Metabolism | hepatic |
| Excretion | renal |
| Identifiers | |
| CAS number | 65527-63-1 |
| ATC code | ? |
| PubChem | CID 44457803 |
| ChemSpider | 21106361 |
| ChEMBL | CHEMBL22258 |
| Synonyms | PRO-LAD, 6-propyl- 6-nor- Lysergic acid diethylamide, (6aR,9R)- N,N- diethyl- 7-propyl- 4,6,6a,7,8,9- hexahydroindolo- [4,3-fg] quinoline- 9- carboxamide |
| Chemical data | |
| Formula | C22H29N3O |
| Mol. mass | 351.50 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
PRO-LAD is an analogue of LSD. It is described by Alexander Shulgin in the book TiHKAL. PRO-LAD is a hallucinogenic drug similar to LSD, and is around as potent as LSD itself with an active dose reported at between 100 and 200 micrograms.[1]
PRO-LAD has been sold by some research chemical suppliers but might be considered illegal in some countries due to its structural similarity to LSD.
|
|||||
| This psychedelics, dissociatives and deliriants-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)